N-Acetyl-D-mannosamine

CAS No. 3615-17-6

N-Acetyl-D-mannosamine( N-Acetylmannosamine | ManNAc | DEXM74 | DEX M 74 | ManNAc | N-Acetylmannosamine )

Catalog No. M27120 CAS No. 3615-17-6

N-Acetylmannosamine is a drug potentially for the treatment of hereditary inclusion body myopathy.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 27 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    N-Acetyl-D-mannosamine
  • Note
    Research use only, not for human use.
  • Brief Description
    N-Acetylmannosamine is a drug potentially for the treatment of hereditary inclusion body myopathy.
  • Description
    N-Acetylmannosamine is a drug potentially for the treatment of hereditary inclusion body myopathy.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    N-Acetylmannosamine | ManNAc | DEXM74 | DEX M 74 | ManNAc | N-Acetylmannosamine
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    Aldose reductase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    3615-17-6
  • Formula Weight
    239.224
  • Molecular Formula
    C8H17NO7
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?H2O : 125 mg/mL (565.07 mM)
  • SMILES
    O.CC(=O)N[C@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Mylari BL, et al. Novel, potent aldose reductase inhibitors: 3,4-dihydro-4-oxo-3-[[5-(trifluoromethyl)-2-benzothiazolyl] methyl]-1-phthalazineacetic acid (zopolrestat) and congeners. J Med Chem. 1991;34(1):108-122.
molnova catalog
related products
  • Comanthoside B

    Comanthoside B is a natural product isolated from the aerial portions of Ruellia tuberosa L with anti-inflammatory and antiseptic activities.

  • PBP 10

    Selective formyl peptide receptor 2 (FPR2) antagonist; cell permeable. Selectively inhibits FPR2-mediated NADPH oxidase activity but has no effect on FPR1 signaling in neutrophils. Displays PIP2 binding activity in vitro and blocks cell motility. Also exhibits antiviral activity against influenza viruses via inhibition of viral-induced ERK activation.

  • Virginiamycin M1

    Virginiamycin M1 (Pristinamycin IIA) is a macrocyclic lactone peptide antibiotic and is a member of the streptogramin A group of antibiotics.